BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 26873707)

  • 21. Health-related quality of life among children with hereditary angioedema.
    Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
    Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid receptor gene polymorphisms in hereditary angioedema with C1-inhibitor deficiency.
    Zotter Z; Nagy Z; Patócs A; Csuka D; Veszeli N; Kőhalmi KV; Farkas H
    Orphanet J Rare Dis; 2017 Jan; 12(1):5. PubMed ID: 28069032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
    Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
    Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.
    Andrási N; Veszeli N; Holdonner Á; Temesszentandrási G; Kőhalmi KV; Varga L; Farkas H
    Int Immunopharmacol; 2020 Mar; 80():106216. PubMed ID: 31982824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
    Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
    Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.
    Obtulowicz P; Piotrowicz-Wojcik K; Dyga W; Stobiecki M; Popiela T; Obtulowicz K
    J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.
    Kőhalmi KV; Mező B; Veszeli N; Benedek S; Fehér A; Holdonner Á; Jesenak M; Varga L; Farkas H
    Int Immunopharmacol; 2020 Apr; 81():106293. PubMed ID: 32078942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
    Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
    Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
    Czaller I; Csuka D; Zotter Z; Veszeli N; Takács E; Imreh É; Varga L; Farkas H
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):175-9. PubMed ID: 27364943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema Attacks.
    Bernstein JA; Tyson C; Relan A; Adams P; Magar R
    J Manag Care Spec Pharm; 2020 Feb; 26(2):203-210. PubMed ID: 31841366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
    Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
    Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
    Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
    Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
    Bork K; Hardt J; Witzke G
    J Allergy Clin Immunol; 2012 Sep; 130(3):692-7. PubMed ID: 22841766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema.
    Kaplan AP; Pawaskar D; Chiao J
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):892-900. PubMed ID: 31655295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study.
    Triggianese P; Guarino MD; Pellicano C; Borzi M; Greco E; Modica S; De Carolis C; Perricone R
    Int Arch Allergy Immunol; 2017; 172(1):55-63. PubMed ID: 28222436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
    Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
    Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guidelines for the diagnosis and treatment of hereditary angioedema].
    Marković AS; Rozmanić V; Anić B; Aberle N; Racić G; Novak S; Sunara D; Grdinić B; Karadza-Lapić L; Radas MR; Karanović B; Kvenić B
    Lijec Vjesn; 2014; 136(5-6):117-29. PubMed ID: 25154179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data.
    Johnson F; Stenzl A; Hofauer B; Heppt H; Ebert EV; Wollenberg B; Lochbaum R; Hahn J; Greve J; Trainotti S
    Clin Rev Allergy Immunol; 2023 Dec; 65(3):354-364. PubMed ID: 37914894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.
    Veszeli N; Csuka D; Zotter Z; Imreh É; Józsi M; Benedek S; Varga L; Farkas H
    Orphanet J Rare Dis; 2015 Dec; 10():156. PubMed ID: 26654922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.